Eric E. Poma

Insider Reports History

Location
New York, NY
Signature
/s/ Andrew Jackson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric E. Poma:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Calidi Biotherapeutics, Inc. Chief Executive Officer Common Stock 25K $50K $2.00 21 Aug 2025 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Stock Option (right to buy) 726K 22 Apr 2025 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Warrant (right to buy) 25K 21 Aug 2025 Direct
Molecular Templates, Inc. Chief Executive Officer and Chief Scientific Officer, Director Stock Option (right to buy) 23.3K 23 Jan 2024 Direct
Calidi Biotherapeutics, Inc. Chief Executive Officer Stock Options (right to buy) 10K 03 Sep 2025 Direct

Insider Reports Filed by Eric E. Poma

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLDI Calidi Biotherapeutics, Inc. 03 Sep 2025 1 $0 4 Chief Executive Officer 05 Sep 2025, 19:56
CLDI Calidi Biotherapeutics, Inc. 25 Aug 2025 2 $50K 4 Chief Executive Officer, Director 25 Aug 2025, 20:47
CLDI Calidi Biotherapeutics, Inc. 22 Apr 2025 1 $0 4 Chief Executive Officer, Director 25 Apr 2025, 06:05
CLDI Calidi Biotherapeutics, Inc. 22 Apr 2025 0 $0 3 Chief Executive Officer, Director 25 Apr 2025, 06:01
MTEM Molecular Templates, Inc. 23 Jan 2024 1 $0 4 Chief Executive Officer and Chief Scientific Officer, Director 25 Jan 2024, 17:32
MTEM Molecular Templates, Inc. 15 Feb 2023 1 $0 4 Chief Executive Officer and Chief Scientific Officer, Director 17 Feb 2023, 07:00
MTEM Molecular Templates, Inc. 27 Apr 2022 4 $24.3K 4 Chief Executive Officer and Chief Scientific Officer, Director 29 Apr 2022, 08:00
MTEM Molecular Templates, Inc. 15 Feb 2022 1 $0 4 Chief Executive Officer and Chief Scientific Officer, Director 17 Feb 2022, 07:00
MTEM Molecular Templates, Inc. 06 Jul 2021 2 $2.53K 4 Chief Executive Officer and Chief Scientific Officer, Director 07 Jul 2021, 07:30